Rituximab-resistant splenic memory B cells and newly engaged naive B cells fuel relapses in patients with immune thrombocytopeniaÉtienne Crickx(Délégation Paris 5), Matthieu Mahévas(Délégation Paris 5)Science Translational MedicineApril 14, 202110.1126/scitranslmed.abc3961Cited by 83SaveCiteExport RISWatch citationsRelated PapersMaturation and persistence of the anti-SARS-CoV-2 memory B cell response|Cell|2021|365